Viveksagar Krishnamurthy Radhakrishna
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Research and Treatments, Advanced biosensing and bioanalysis techniques, Colorectal Cancer Treatments and Studies, Melanoma and MAPK Pathways
Most-Cited Works
- → Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition(2016)978 cited
- → Studying clonal dynamics in response to cancer therapy using high-complexity barcoding(2015)521 cited
- → PISCES: a package for rapid quantitation and quality control of large scale mRNA-seq datasets(2020)5 cited
- → Abstract 3240: Understanding clonal complexity of a tumor xenograft model via cellular barcoding technology(2015)
- → Abstract 394: In vivo shRNA screens under treatment pressure by BRAF and MEK inhibitors to identify novel combination treatment strategies for BRAF-mutant colorectal cancer(2019)
- → Abstract 394:In vivoshRNA screens under treatment pressure by BRAF and MEK inhibitors to identify novel combination treatment strategies forBRAF-mutant colorectal cancer(2019)
- → Abstract 2847: High complexity barcoding to study clonal dynamics in response to cancer therapy(2015)